Connection

John Gnann to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications John Gnann has written about Dose-Response Relationship, Drug.
John Gnann
Connection Strength
0.012
Dose-Response Relationship, Drug
  1. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005 Aug; 11(8):941-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.